GRANTEES Selective 5-HT3 Receptor Antagonist Antiemetic
Prevents nausea. Restores comfort. Improves life.
Franchise & Quality Guarantee
GRANTEES
FAST RELIEF. NO NAUSEA. JUST LIFE.
“Prevents nausea. Restores comfort. Improves life.”
Formulation Overview
GRANTEES is an advanced Orally Disintegrating Tablet (ODT) featuring Granisetron HCL. By selectively blocking 5-HT3 serotonin receptors both centrally in the chemoreceptor trigger zone (CTZ) and peripherally on vagal nerve terminals, it delivers rapid emetic suppression without the need for water swallowing.
Active Pharmaceutical Ingredients (APIs)Each Unit Contains
| Ingredient Name | Dosage / Strength |
|---|---|
| Granisetron HCL | 1mg |
Therapeutic Indications & Clinical Use
Key Formulation Advantages
As directed by the Physician. Place on tongue to disintegrate.
Store in a dry place below 30°C. Protect from moisture.
Distribute GRANTEES in Your Territory
Secure exclusive district monopoly marketing rights for GRANTEES (Tablet). We provide attractive distributor profit margins, digital promotional flyers, and prompt dispatch from Ahmedabad, Gujarat across 15+ states.
Direct communication with Vikson Lifescience PCD Franchise Management Team, Gheekanta, Ahmedabad.
More Formulations in Tablets
Complete support. Comfort through every trimester.